CNS Pharmaceuticals (CNSP) Financials: Revenue & Earnings

CNSP price $5.01 -0.07 -1.38%

Ticker
CNSP
Price
$5.01
Change
-0.07 -1.38%
Market cap ?
$7.32M
P/E ?
-0.21
Forward P/E ?
2.20
Dividend yield ?
0.00%
Beta ?
1.02
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
37
Value
58
Quality
52
Growth
0

Stocklytics score rationale: value 58, quality 52, growth 0.

Financials

201720182019202020212022202320242025
000000000

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To…

Fair value

CNSP fair value $89.19. Price $5.01. Price is 94% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CNSP

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-18—-0.27——
2026-08-12-0.38-0.24——
2026-05-14-7.30-5.37——
2026-03-31-5.09-5.09——
2025-11-14-5.76-6.63——
2025-08-14-6.42-9.60——
2025-05-15-18.97-24.00——
2025-03-31-447.96-87.96——
2024-11-14-150.06-0.10——
2024-08-14-4,033.61-3,585.43——
2024-05-15-12,304.92———
2024-04-01-28,511.40-57,000.006.36K—
2023-11-14-32,412.97-51,900.00——
2023-08-14-31,212.48-84,600.00——
2023-05-15-77,731.09———
2023-04-03-9,275.00-6,000.00——
2022-11-10-8,104.05-2.40——
2022-08-12-8,104.05-90.00——
2022-05-16-6,303.15-2.40——
2022-03-03-9,004.50-18,909.45——
2021-11-12-12,606.30-18,909.45——
2021-08-13-13,506.75-14,407.20——
2021-05-14-13,506.75-3.60——
2021-02-12-16,208.10-8,104.05——
2020-11-12-10,805.40-3.60——
2020-08-10-13,506.75-2.40——
2020-05-15-10,805.40-3.00——
2020-03-12-15,307.65-0.90——
2019-12-20-1.50-0.90——
2019-06-30-0.47———
2019-03-31-0.23———
2018-12-31-7.29———
2018-09-30-0.21———
2018-06-30-0.28———
2018-03-31-0.34———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-14Levin RamiSell4.75K——
2026-08-14Levin RamiSell4.75K——
2026-05-18Fisher MichalBuy2.00K$5.0010.00K
2026-05-18Charles Faith L.Buy7.10K$4.7934.00K
2026-05-04Fisher MichalOther0——
2026-03-02Faulkner EricBuy9.50K——
2026-03-02Faulkner EricOther0——
2026-03-02O'Loughlin SteveBuy9.50K——
2026-03-02O'Loughlin SteveOther0——
2026-01-01Levin RamiBuy19.00K——
2026-01-01Levin RamiOther0——
2025-11-17Keyes Jeffry R.Buy1.52K$12.4818.93K
2025-11-17Cockroft Bettina M.Buy1.52K$12.4818.93K
2025-11-17Climaco John MBuy9.76K$30.00292.83K
2025-11-17Mahery AmyBuy1.52K$12.4818.93K
2025-11-17Charles Faith L.Buy1.52K$12.4818.93K
2025-11-17Downs ChristopherBuy4.88K$30.00146.43K
2025-11-17Gumulka JerzyBuy1.52K$12.4818.93K
2024-07-30Cortice Biosciences, Inc.Other0——
2024-07-29Cortice Biosciences, Inc.Sell0——
2024-04-08Mahery AmyBuy17.50K——
2024-04-08Mahery AmyBuy17.50K$0.264.53K
2024-04-08Keyes Jeffry R.Buy17.50K——
2024-04-08Keyes Jeffry R.Buy17.50K$0.264.53K
2024-04-08Gumulka JerzyBuy17.50K——
2024-04-08Gumulka JerzyBuy17.50K$0.264.53K
2024-04-08Evans Carl AnthonyBuy17.50K——
2024-04-08Evans Carl AnthonyBuy17.50K$0.264.53K
2024-04-08Downs ChristopherBuy40.00K——
2024-04-08Downs ChristopherBuy40.00K$0.2610.34K
2024-04-08Cockroft Bettina M.Buy17.50K——
2024-04-08Cockroft Bettina M.Buy17.50K$0.264.53K
2024-04-08Climaco John MBuy83.00K——
2024-04-08Climaco John MBuy83.00K$0.2621.46K
2024-04-08Charles Faith L.Buy17.50K——
2024-04-08Charles Faith L.Buy17.50K$0.264.53K
2024-02-01Mahery AmyBuy12.42K$0.253.14K
2024-02-01Gumulka JerzyBuy33.33K$0.3010.00K
2024-02-01Gumulka JerzyBuy33.33K$0.3010.00K
2024-02-01Gumulka JerzyBuy33.33K$0.3010.00K
2024-02-01Evans Carl AnthonyBuy33.33K$0.3010.00K
2024-02-01Evans Carl AnthonyBuy33.33K$0.3010.00K
2024-02-01Evans Carl AnthonyBuy33.33K$0.3010.00K
2024-02-01Downs ChristopherBuy66.67K$0.3020.00K
2024-02-01Downs ChristopherBuy66.67K$0.3020.00K
2024-02-01Downs ChristopherBuy66.67K$0.3020.00K
2024-02-01Climaco John MBuy166.67K$0.3050.00K
2024-02-01Climaco John MBuy166.67K$0.3050.00K
2024-02-01Climaco John MBuy166.67K$0.3050.00K
2024-02-01Mahery AmyOther0——
2023-09-21Gumulka JerzyBuy39.48K$1.0943.03K
2023-09-21Evans Carl AnthonyBuy39.48K$1.0943.03K
2023-09-21Keyes Jeffry R.Buy39.48K$1.0943.03K
2023-09-21Cockroft Bettina M.Buy9.47K$1.0910.33K
2023-09-21Charles Faith L.Buy26.32K$1.0928.68K
2023-09-21Andraczke AndrzejBuy39.48K$1.0943.03K
2023-09-21Keyes Jeffry R.Buy68.96K$1.0975.17K
2023-09-21Gumulka JerzyBuy68.96K$1.0975.17K
2023-09-21Evans Carl AnthonyBuy68.96K$1.0975.17K
2023-09-21Cockroft Bettina M.Buy16.55K$1.0918.04K
2023-09-21Charles Faith L.Buy45.97K$1.0950.11K
2023-09-21Andraczke AndrzejBuy68.96K$1.0975.17K
2023-09-14Cockroft Bettina M.Buy6.50K$2.2714.76K
2023-08-22Downs ChristopherBuy27.00K$1.2734.18K
2023-08-16Climaco John MBuy2.75K$1.804.94K
2023-05-05Cockroft Bettina M.Buy2.10K$1.673.51K
2023-05-05Cockroft Bettina M.Buy8.30K$1.6713.86K
2023-05-03Cockroft Bettina M.Other0——
2023-04-28Climaco John MSell1.25K——
2023-04-28Climaco John MBuy1.25K——
2023-04-28Downs ChristopherSell521——
2023-04-28Downs ChristopherBuy521——
2023-04-19Gumulka JerzyBuy2.50K$1.704.25K
2023-04-17Downs ChristopherBuy3.10K$3.209.92K
2023-04-12Climaco John MBuy15.00K$0.6910.41K
2023-04-10Gumulka JerzyBuy7.17K$0.745.31K
2023-03-29Climaco John MBuy16.47K——
2023-03-29Downs ChristopherBuy6.07K——
2023-03-28Priebe WaldemarSell10.00K$1.0410.40K
2023-03-27Priebe WaldemarSell5.00K$1.095.45K
2023-03-24Priebe WaldemarSell5.00K$1.085.40K
2023-03-23Priebe WaldemarSell10.00K$1.0810.80K
2023-03-22Priebe WaldemarSell5.00K$1.085.40K
2023-03-21Priebe WaldemarSell5.00K$1.105.50K
2023-03-20Priebe WaldemarSell5.00K$1.085.40K
2023-03-17Priebe WaldemarSell5.00K$1.135.65K
2023-03-16Priebe WaldemarSell5.00K$1.246.20K
2023-03-15Priebe WaldemarSell5.00K$1.226.10K
2023-03-14Priebe WaldemarSell5.00K$1.356.75K
2023-03-13Priebe WaldemarSell5.00K$1.306.50K
2023-03-10Priebe WaldemarSell5.00K$1.296.45K
2022-12-30Charles Faith L.Buy3.50K——
2022-12-30Charles Faith L.Other———
2022-12-30Charles Faith L.Other0——
2022-12-09Priebe WaldemarSell2.80K$2.436.80K
2022-12-08Priebe WaldemarSell5.50K$2.4013.20K
2022-12-07Priebe WaldemarSell5.50K$2.4613.53K
2022-12-06Priebe WaldemarSell5.50K$2.4713.59K
2022-04-28Downs ChristopherBuy250.00K——
2022-04-28Climaco John MBuy600.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 11, holders 0 vs prior quarter. Ownership 4.10%.

HolderSharesChangeChange %Value
IKARIAN CAPITAL, LLC135.83K90.00K+196.38%649.27K
ADAR1 CAPITAL MANAGEMENT, LLC70.00K70.00KNew334.60K
STONEPINE CAPITAL MANAGEMENT, LLC41.57K-19.43K-31.85%198.72K
BOOTHBAY FUND MANAGEMENT, LLC13.52K00.00%64.64K
VANGUARD FIDUCIARY TRUST CO10.23K10.23KNew48.88K
VANGUARD CAPITAL MANAGEMENT LLC6.99K6.99KNew33.43K
UBS GROUP AG1.46K732+100.41%6.98K
TOWER RESEARCH CAPITAL LLC (TRC)799-511-39.01%3.82K
BARCLAYS PLC1919New91
BARRETT & COMPANY, INC.800.00%38
DANSKE BANK A/S100.00%5
MAI CAPITAL MANAGEMENT0-3-100.00%0
CITIGROUP INC0-1-100.00%0
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD0-1-100.00%0
GEODE CAPITAL MANAGEMENT, LLC0-23.19K-100.00%0

Earnings and financials

CNS Pharmaceuticals, Inc. (CNSP) trades at $5.01, with a market cap of $7.32M and a trailing P/E of -0.21. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CNS Pharmaceuticals (CNSP) Financials: Revenue & Earnings

CNSP$5.01-0.07 -1.38%

$7.32M

Market Cap

-0.21

P/E

2.20

Forward P/E

37

Score

Price History